Literature DB >> 29713848

GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation.

Shishuang Wu1, Jiale Fu1, Yu Dong1, Qinghao Yi1, Dong Lu2,3, Weibing Wang1, Yanhua Qi1,4, Rutong Yu5,6, Xiuping Zhou7,8.   

Abstract

INTRODUCTION: Our recent work reported that GOLPH3 promotes glioma progression via inhibiting endocytosis and degradation of EGFR. The current study aimed to explore the potential regulating mechanism of GOLPH3 on JAK2-STAT3 signaling, a downstream effector of EGFR, in glioma progression.
METHODS: The expression of JAK2, STAT3 and GOLPH3 in glioma tissues was detected by western blotting, tissue microarray and immunohistochemistry. The U251 and U87 cells with GOLPH3 down-regulation or over-expression were generated by lentivirus system. The effects of GOLPH3 on the activity of JAK2 and STAT3 were detected by western blotting and reverse transcription polymerase chain reaction. Co-immunoprecipitation was used to detect the association of GOLPH3 with JAK2 and STAT3. Cell proliferation was detected by CCK8 and EdU assay.
RESULTS: The level of JAK2, STAT3 and GOLPH3 were significantly up-regulated and exhibited pairwise correlation in human glioma tissues. The level of p-JAK2 and p-STAT3, as well as the mRNA and protein levels of cyclin D1 and c-myc, two target genes of STAT3, decreased after GOLPH3 down-regulation, while they increased after GOLPH3 over-expression both in U251 and U87 cells. Interestingly, GOLPH3, JAK2 and STAT3 existed in the same protein complex and GOLPH3 affected the interaction of JAK2 and STAT3. Importantly, down-regulation of STAT3 partially abolished cell proliferation induced by GOLPH3 over-expression.
CONCLUSIONS: GOLPH3 may act as a scaffold protein to regulate JAK2-STAT3 interaction and then its activation, which therefore mediates the effect of GOLPH3 on cell proliferation.

Entities:  

Keywords:  GOLPH3; Glioma; JAK2; Proliferation; STAT3

Mesh:

Substances:

Year:  2018        PMID: 29713848     DOI: 10.1007/s11060-018-2884-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  41 in total

Review 1.  Potential roles of Stat1 and Stat3 in cellular transformation.

Authors:  J F Bromberg; J E Darnell
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1999

2.  GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro.

Authors:  Xu Zhang; Zhijun Ding; Jianbing Mo; Ben Sang; Qiong Shi; Jinxia Hu; Shao Xie; Wenjian Zhan; Dong Lu; Minglin Yang; Wenbin Bian; Xiuping Zhou; Rutong Yu
Journal:  Mol Carcinog       Date:  2014-08-23       Impact factor: 4.784

3.  Golgi phosphoprotein 3 determines cell binding properties under dynamic flow by controlling Golgi localization of core 2 N-acetylglucosaminyltransferase 1.

Authors:  Mohamed F Ali; Vishwanath B Chachadi; Armen Petrosyan; Pi-Wan Cheng
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

4.  DNA damage triggers Golgi dispersal via DNA-PK and GOLPH3.

Authors:  Suzette E Farber-Katz; Holly C Dippold; Matthew D Buschman; Marshall C Peterman; Mengke Xing; Christopher J Noakes; John Tat; Michelle M Ng; Juliati Rahajeng; David M Cowan; Greg J Fuchs; Huilin Zhou; Seth J Field
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

5.  Direct involvement of phosphatidylinositol 4-phosphate in secretion in the yeast Saccharomyces cerevisiae.

Authors:  H Hama; E A Schnieders; J Thorner; J Y Takemoto; D B DeWald
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

6.  Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.

Authors:  Zhaolei Zeng; Huanxin Lin; Xiaohui Zhao; Guanglin Liu; Xi Wang; Ruihua Xu; Kun Chen; Jun Li; Libing Song
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

Review 7.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

8.  EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy.

Authors:  Hua Jin; Jiang Pi; Yue Zhao; Jinhuan Jiang; Ting Li; Xueyi Zeng; Peihui Yang; Colin E Evans; Jiye Cai
Journal:  Nanoscale       Date:  2017-11-02       Impact factor: 7.790

Review 9.  Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.

Authors:  Lisa N Heppler; David A Frank
Journal:  Trends Cancer       Date:  2017-11-10

10.  EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.

Authors:  Qi-Wen Fan; Christine K Cheng; W Clay Gustafson; Elizabeth Charron; Petra Zipper; Robyn A Wong; Justin Chen; Jasmine Lau; Christiane Knobbe-Thomsen; Michael Weller; Natalia Jura; Guido Reifenberger; Kevan M Shokat; William A Weiss
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

View more
  13 in total

Review 1.  GOLPH3: a Golgi phosphatidylinositol(4)phosphate effector that directs vesicle trafficking and drives cancer.

Authors:  Ramya S Kuna; Seth J Field
Journal:  J Lipid Res       Date:  2018-09-28       Impact factor: 5.922

2.  Long Intergenic Noncoding RNA 00641 Promotes Growth and Invasion of Colorectal Cancer through Regulating miR-450b-5p/GOLPH3 Axis.

Authors:  Zhongshi Hong; Jianpeng Pan; Mingliang Chen; Xian Deng; Zhichuan Chen; Chunxiao Wang; Chengzhi Qiu
Journal:  J Oncol       Date:  2022-06-15       Impact factor: 4.501

3.  GOLPH3 promotes glioma progression by enhancing PHB2-mediated autophagy.

Authors:  Kai Wang; Yanhua Qi; Xu Wang; Yushuai Liu; Min Zhao; Ding Zhou; Yu Zhang; Yan Wang; Rutong Yu; Xiuping Zhou
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

4.  Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.

Authors:  Anne-Florence Blandin; Elisabete Cruz Da Silva; Marie-Cécile Mercier; Oleksandr Glushonkov; Pascal Didier; Stéphane Dedieu; Cristophe Schneider; Jessica Devy; Nelly Etienne-Selloum; Monique Dontenwill; Laurence Choulier; Maxime Lehmann
Journal:  Cell Mol Life Sci       Date:  2020-11-05       Impact factor: 9.261

5.  TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance.

Authors:  Zonghui Ding; Jean M Kloss; Serdar Tuncali; Nhan L Tran; Joseph C Loftus
Journal:  Neoplasia       Date:  2020-07-03       Impact factor: 5.715

6.  The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner.

Authors:  Cecilia Arriagada; Charlotte Luchsinger; Alexis E González; Tomás Schwenke; Gloria Arriagada; Hugo Folch; Pamela Ehrenfeld; Patricia V Burgos; Gonzalo A Mardones
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

Review 7.  Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer.

Authors:  Stefano Sechi; Anna Frappaolo; Angela Karimpour-Ghahnavieh; Roberto Piergentili; Maria Grazia Giansanti
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

8.  IL-22 promotes tumor growth of breast cancer cells in mice.

Authors:  Ying Zhang; Cong Liu; Jun Gao; Siqi Shao; Yingying Cui; Songlou Yin; Bin Pan
Journal:  Aging (Albany NY)       Date:  2020-07-10       Impact factor: 5.682

9.  High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma.

Authors:  Shuwei Chen; Huan Li; Xiyuan Li; Wenkuan Chen; Xing Zhang; Zhongyuan Yang; Zhipeng Chen; Jingtao Chen; Ying Zhang; Dingbo Shi; Ming Song
Journal:  Cancer Med       Date:  2020-04-19       Impact factor: 4.452

10.  MiR-3150b-3p inhibits the progression of colorectal cancer cells via targeting GOLPH3.

Authors:  Weiqing Zhang; Xiaoyan Chen; Junzhi Jia
Journal:  J Investig Med       Date:  2019-11-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.